COVID-19 Treatment

Monoclonal Antibodies

We currently stock the following monoclonal antibody treatments: 

 Regen-CoV (Casirivimab / Imdevimab)**

Xevudy (Sotrovimab)

These infusions are administered intravenously over 30 minutes followed by a 1 hour period of observation.

**We can administer Regen-CoV as 4 subcutaneous injections, however we find this to be far more painful and is not the preferred route of administration according to the manufacturer.  

Currenty Eligibility Criteria from the FDA

Criteria to meet

Age 12 and up and not hospitalized

Mild to Moderate COVID-19 and at high risk for progressing to severe COVID-19 due to one or more fo the following:

  • Age > 65
  • BMI > 25
  • Chronic Kidney Disease
  • Pregnancy
  • Diabetes
  • Immunosuppressive disease
  • Currently receiving immunosuppressive treatment
  • Cardiovascular disease
  • Hypertension
  • COPD or other chronic respiratory disease such as Asthma
  • Sickle Cell Disease
  • Congenital or acquired heart disease
  • Neurodevelopmental disorder (e.g. cerebrala palsy)
  • A medical-related technological dependence (e.g. tracheostomy)

Symptom onset less than 10 days ago

Not currently using supplemental oxygen

REFERRAL REQUIRED

If we have not seen you as a patient, please have your doctor download and fax us the completed Referral / Certification form above. If this is not possible please call us for assistance so our physician can certify you.

Phone Number

469-769-5688

Email address

rrc@rockwallrapidcare.com

Secured By miniOrange